Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in thousands)
| 05-2022 | 05-2021 | 05-2020 | 05-2019 | 05-2018 | |
| Sales | 293 | 0 | 133 | 240 | 27 |
| Cost of Goods | 224 | N/A | N/A | N/A | N/A |
| Gross Profit | 69 | N/A | N/A | N/A | N/A |
| Operating Expenses | 3,667 | 3,331 | 2,749 | 2,742 | 2,450 |
| Operating Income | -3,597 | -3,331 | -2,616 | -2,502 | -2,423 |
| Interest Expense | 567 | 189 | N/A | N/A | N/A |
| Other Income | 475 | -900 | 8 | 43 | 15 |
| Pre-tax Income | -3,689 | -4,420 | -2,607 | -2,459 | -2,408 |
| Net Income Continuous | -3,689 | -4,420 | -2,607 | -2,459 | -2,408 |
| Net Income | $-3,689 | $-4,420 | $-2,607 | $-2,459 | $-2,408 |
| EPS Basic Total Ops | -0.10 | -0.13 | -0.10 | -0.10 | -0.11 |
| EPS Basic Continuous Ops | -0.10 | -0.13 | -0.10 | -0.10 | -0.11 |
| EPS Diluted Total Ops | -0.10 | -0.13 | -0.10 | -0.10 | -0.11 |
| EPS Diluted Continuous Ops | -0.10 | -0.13 | -0.10 | -0.10 | -0.11 |
| EBITDA(a) | $-2,488 | $-3,685 | $-2,320 | $-2,421 | $-2,372 |